Meeting of the Advisory Committee on Blood Safety and Availability, 42405 [E6-11962]
Download as PDF
<![CDATA[
42405
Federal Register / Vol. 71, No. 143 / Wednesday, July 26, 2006 / Notices
TABLE I—Continued
Approximate
funding available
States/populations/areas to be served
Region IX:
Navajo Nation ...........................................................................................................
Commonwealth of the Northern Mariana Islands ....................................................
Federated States of Micronesia ...............................................................................
Nevada, Washoe County .........................................................................................
Region X:
Alaska .......................................................................................................................
Oregon ......................................................................................................................
Idaho .........................................................................................................................
Washington ...............................................................................................................
Washington, Seattle area .........................................................................................
Dated: July 19, 2006.
Evelyn M. Kappeler,
Acting Director, Office of Population Affairs.
[FR Doc. E6–11963 Filed 7–25–06; 8:45 am]
03/01/07
09/01/06
03/01/07
03/01/07
07/01/07
01/01/07
07/01/07
07/01/07
420,000
2,452,000
1,568,000
3,240,000
159,000
03/01/07
03/01/07
03/01/07
09/01/06
03/01/07
07/01/07
07/01/07
07/01/07
01/01/07
07/01/07
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood Safety and Availability
Office of Public Health and
Science, Office of the Secretary, DHHS.
ACTION: Notice.
AGENCY:
Office of the National Coordinator;
American Health Information
Community Biosurveillance Data
Steering Group Meeting
ACTION:
Announcement of meeting.
SUMMARY: This notice announces the
third meeting of the American Health
Information Community Biosurveillance
Data Steering Group in accordance with
the Federal Advisory Committee Act
(Pub. L. No. 92–463, 5 U.S.C., App.).
DATES:
August 8, 2006 from 2 p.m. to 4
p.m.
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090 (you
will need a photo ID to enter a Federal
building).
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic.html.
The
meeting will be available via Internet
access. Go to https://www.hhs.gov/
healthit/ahic.html for additional
information on the meeting.
sroberts on PROD1PC70 with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: July 19, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–6485 Filed 7–25–06; 8:45am]
BILLING CODE 4150–24–M
VerDate Aug<31>2005
17:16 Jul 25, 2006
Jkt 208001
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood Safety
and Availability (ACBSA) will hold a
meeting. The ACBSA will meet to
review progress and solicit additional
input regarding numerous
recommendations made during the past
year, specifically biovigilance of blood
components and its derivatives, cells,
tissues, and organs. Vigilance is
recognized as a necessary step in
monitoring outcomes in a quality
assurance process toward the goal of
providing safe and available biological
products (i.e., blood components and
derivatives, cells, tissues and organs)
and improvement of care of the donor
and recipient. Elements necessary for
vigilant surveillance are detection,
analysis, reporting, utilizations,
research, education, and management of
outcomes, including emerging or reemerging infectious and non-infectious
events of transfusion and/or
transplantation, will be discussed.
DATES: The meeting will take place
Wednesday, August 30 and Thursday,
August 31, 2006 from 9 a.m. to 5 p.m.
ADDRESSES: Marriott Crystal Gateway,
1700 Jeff Davis Highway, Arlington, VA
22202.
FOR FURTHER INFORMATION CONTACT: Jerry
A. Holmberg, PhD, Executive Secretary,
Advisory Committee on Blood Safety
and Availability, Office of Public Health
and Science, Department of Health and
Human Services, 1101 Wootton
Parkway, Room 250, Rockville, MD
20852, (240) 453–8809, fax (240) 453–
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Approx. grant
funding date
640,000
170,000
411,000
708,000
BILLING CODE 4150–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Application due
date
8456, e-mail
jholmberg@osophs.dhhs.gov.
Public
comment will be solicited at the
meeting and will be limited to five
minutes per speaker. Individuals who
wish to present comments to the
Committee should contact the Executive
Secretary to register no later than close
of business on August 25, 2006.
Individuals who wish to have printed
material distributed are encouraged to
provide thirty (30) copies to the
Executive Secretary no later than close
of business August 25, 2006. Likewise,
those who wish to utilize electronic data
projection to the Committee must
submit their materials to the Executive
Secretary prior to close of business
August 25, 2006.
SUPPLEMENTARY INFORMATION:
Dated: July 20, 2006.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E6–11962 Filed 7–25–06; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006O–0231]
Over-the-Counter Drug Products;
Safety and Efficacy Review; Additional
Sunscreen Ingredient
AGENCY:
Food and Drug Administration,
HHS.
Notice of eligibility; request for
data and information.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
call-for-data for safety and effectiveness
information on the following condition
as part of FDA’s ongoing review of overthe-counter (OTC) drug products:
Diethylhexyl butamido triazone, up to 3
percent, as a sunscreen single active
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 71, Number 143 (Wednesday, July 26, 2006)]
[Notices]
[Page 42405]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-11962]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Blood Safety and
Availability
AGENCY: Office of Public Health and Science, Office of the Secretary,
DHHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Advisory Committee on Blood Safety and Availability (ACBSA) will
hold a meeting. The ACBSA will meet to review progress and solicit
additional input regarding numerous recommendations made during the
past year, specifically biovigilance of blood components and its
derivatives, cells, tissues, and organs. Vigilance is recognized as a
necessary step in monitoring outcomes in a quality assurance process
toward the goal of providing safe and available biological products
(i.e., blood components and derivatives, cells, tissues and organs) and
improvement of care of the donor and recipient. Elements necessary for
vigilant surveillance are detection, analysis, reporting, utilizations,
research, education, and management of outcomes, including emerging or
re-emerging infectious and non-infectious events of transfusion and/or
transplantation, will be discussed.
DATES: The meeting will take place Wednesday, August 30 and Thursday,
August 31, 2006 from 9 a.m. to 5 p.m.
ADDRESSES: Marriott Crystal Gateway, 1700 Jeff Davis Highway,
Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive
Secretary, Advisory Committee on Blood Safety and Availability, Office
of Public Health and Science, Department of Health and Human Services,
1101 Wootton Parkway, Room 250, Rockville, MD 20852, (240) 453-8809,
fax (240) 453-8456, e-mail jholmberg@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Public comment will be solicited at the
meeting and will be limited to five minutes per speaker. Individuals
who wish to present comments to the Committee should contact the
Executive Secretary to register no later than close of business on
August 25, 2006. Individuals who wish to have printed material
distributed are encouraged to provide thirty (30) copies to the
Executive Secretary no later than close of business August 25, 2006.
Likewise, those who wish to utilize electronic data projection to the
Committee must submit their materials to the Executive Secretary prior
to close of business August 25, 2006.
Dated: July 20, 2006.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and
Availability.
[FR Doc. E6-11962 Filed 7-25-06; 8:45 am]
BILLING CODE 4150-41-P
